HIV Study Attempts to Salvage Lost Lives CDC Daily UpdateImportant note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow




HIV Study Attempts to Salvage Lost Lives

Calgary Herald (12.27.01) - Friday, December 28, 2001
Sharon Kirkey


Ottawa researchers are developing a major study of ways to "salvage" the lives of HIV-positive patients who are facing decreased drug options due to the failure of their antiretroviral medications. The drugs that have saved thousands of lives are now failing a growing number of patients.

Ottawa Hospital will be the lead Canadian site for an international study designed to find the "salvage therapy" for patients with HIV/AIDS whose bodies are no longer responding to standard treatment. The Optima study will involve about 80 centers across Canada, the United States and the United Kingdom.

Dr. Bill Cameron of Ottawa Hospital's department of infectious diseases and the lead Canadian researcher for the trial said the study "will address a pressing need for patients who have used, and lost, their treatment options."

"Things have changed so much that, in 1990, having HIV infection was a death sentence. In the year 2001, having HIV is a life sentence - in terms of medications. If you and your doctor can sort out the medication that will be most agreeable in terms of tolerance and safety, as long as you take those pills like a robot, you can expect to live out your natural life," provided there are no serious long-term complications, Cameron said.

But for up to 40 percent of patients, the drugs fail within a year of starting treatment. In some cases, the drugs fail to suppress the virus for more than a few months. Some patients can't follow the rigid dosing regimen. Some patients can't tolerate the serious side effects. In these cases, important questions emerge, according to Cameron. "What do we do now?" "Would it be better to stop treatment for three months, take a break... then restart after three or four months off pills?"

The Optima trial will test two strategies: One will compare a drug holiday with uninterrupted treatment. Another salvage strategy will compare "treatment intensification"- using multiple antiretrovirals - compared to "your best choice of standard therapy," Cameron said.
011228
AD012249


Copyright © 2001 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.